GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Three-time NBA slam dunk champion Nate Robinson said Friday that he was receiving a kidney transplant. The 5-foot-9 guard who ...

Older adults with advanced kidney disease are often motivated to receive a transplant but may face emotional and psychosocial ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Chronic kidney disease is a common complication for people living with type 2 diabetes. Diabetes is the leading cause of ...

They eventually landed at the University of Virginia Children’s Hospital where Kamden was diagnosed with nephrotic syndrome, ...

Former Washington Husky star and NBA point guard Nate Robinson, who has dealt with renal failure for the past seven years, ...

Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

Kidney disease affects millions of Americans, with Black communities facing disproportionately higher risks due to genetic factors, socioeconomic challenges, ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.